India  

Covid-19 vaccine: Bharat Biotech confirms adverse event during Covaxin phase 1 trial reported within 24 hours

DNA Sunday, 22 November 2020 ()
The adverse event occurred in a 35-year old participant with no co-morbidities, who was part of Phase 1 trials at a site in western India.
0
shares
ShareTweetSavePostSend
 
Video Credit: Oneindia - Published
News video: Haryana Health Minister Anil Vij becomes the 1st volunteer of Covid vaccine in Haryana|Oneindia News

Haryana Health Minister Anil Vij becomes the 1st volunteer of Covid vaccine in Haryana|Oneindia News 01:00

Haryana Health Minister Anil Vij has become the first volunteer of the Covaxin in his state of Haryana. He was administered a trial dose of a coronavirus vaccine today in a hospital in the state's Ambala Cantonment. The third phase trial of Bharat Biotech's Covaxin began in Haryana today. Just days...

💡 newsR Knowledge: Other News Mentions

Bharat Biotech Bharat Biotech Indian biotechnology company and vaccine manufacturer

Bharat Biotech expects COVID-19 vaccine to be atleast 60% effective, launch likely in Q2 of 2021

Bharat Biotech launched its third phase trials of Covaxin in Haryana on November 20. It had applied for permission to the DGCI on October 2
DNA
'Covaxin phase-3 trial probably largest clinical trial in India': Principal Investigator [Video]

'Covaxin phase-3 trial probably largest clinical trial in India': Principal Investigator

Phase-3 trial of Covaxin is very crucial, and this is the largest clinically phase-3 trial in India, said Dr. E Venkata Rao, Principal Investigator in the Covaxin human trial to ANI on November 21. He said, "After the success of Phase-1 and 2 of this indigenously developed vaccine by Bharat Biotech. Now the vaccine has come in to the phase-3, phase-1 was the safety profile, and in phase-2 we looked for antibodies which are sufficiently developed in the body or not. Phase-3 is crucial face where we will look at if the vaccine is effective enough in preventing the development of the disease. Probably, Covaxin phase-3 trail is the largest clinical trial in India." Covaxin entered Phase-3 of human trial in Bhubaneswar.

Credit: ANI    Duration: 01:36Published

Indian vaccine co had adverse event; experts seek more transparency

Hyderabad-based Bharat Biotech’s potential Covid-19 vaccine reported a serious adverse event during clinical trials in August, even as it’s now initiated the..
IndiaTimes

Coronavirus disease 2019 Coronavirus disease 2019 Disease caused by severe acute respiratory syndrome coronavirus 2

States must start working on cold storage facilities for COVID vaccine: PM Modi [Video]

States must start working on cold storage facilities for COVID vaccine: PM Modi

Prime Minister Narendra Modi interacted with Chief Ministers via video-conferencing on Nov 24. PM Modi said "Seeing good recovery rates, many think virus is weak and they'll recover soon, this has lead to rampant carelessness. Those working on vaccine are doing it but we need to focus on ensuring that people are alert and transmission is curbed. We have to bring positivity rate under 5%." He further said, "Vaccine distribution strategy will be chalked out in collective coordination with states. States must also start working on cold storage facilities."

Credit: ANI    Duration: 03:03Published
We still don't have answers for doses, price for COVID vaccine: PM Modi [Video]

We still don't have answers for doses, price for COVID vaccine: PM Modi

Prime Minister Narendra Modi interacted with Chief Ministers via video-conferencing on Nov 24. He said, "Government of India is keeping a track of each step in vaccine development. We are in touch with Indian vaccine developers and manufacturers. We are also in touch with global regulators, governments of other countries, multinational organisations and international companies." He further said, "It is not certain whether there will be one, two or three doses of a vaccine. It is also not decided what will be the price of the vaccine. We still don't have answers to these questions."

Credit: ANI    Duration: 01:30Published
Mortal remains of former CM Tarun Gogoi brought to Rajiv Bhawan in Guwahati [Video]

Mortal remains of former CM Tarun Gogoi brought to Rajiv Bhawan in Guwahati

Mortal remains of former chief minister of Assam, Tarun Gogoi was brought to Rajiv Bhawan (Assam Pradesh Congress Committee) in Guwahati on November 24. He passed away on November 23 at GMCH in Guwahati. Gogoi was undergoing treatment at GMCH for post-COVID complications. His health condition was in critical stage.

Credit: ANI    Duration: 01:25Published
‘Ramp up cold storage facilities for Covid vaccines’: PM Modi tells CMs [Video]

‘Ramp up cold storage facilities for Covid vaccines’: PM Modi tells CMs

Prime Minister Narendra Modi urged state governments to start work on cold storage facilities during his meeting with Chief Ministers to discuss the Covid crisis. ‘Today I spoke to chief ministers of states where the situation is deteriorating. Discussions over the status and distribution of vaccine took place and the picture is clearer now. As a result of joint efforts, today India is in a better situation than other countries when it comes to recovery and fatality rates. Vaccine distribution strategy will be chalked out in collective coordination with states. States must also start working cold storage facilities,’ PM Modi said in his closing remarks. PM Modi also said that efforts need to be made to bring the positivity rate under 5% and the fatality rate under 1%. ‘We need to speed up our efforts to reduce transmission of the virus. Testing, confirmation, contact tracing and data must be given top priority,’ he said. The Prime Minister also urged Chief Ministers to share their vaccine distribution plans with the Centre. He also warned people to guard against any form of laxity in dealing with the virus. Watch the full video for all the details.

Credit: HT Digital Content    Duration: 09:27Published

You Might Like


Related videos from verified sources

Watch: Haryana Health Minister Anil Vij administered trial dose of Covaxin [Video]

Watch: Haryana Health Minister Anil Vij administered trial dose of Covaxin

Haryana Health Minister Anil Vij was administered a trial dose of Covaxin on Friday. 67-year old Vij was administered the trial dose at the Civil Hospital at Ambala Cantt. On Wednesday, Vij had said..

Credit: HT Digital Content     Duration: 01:43Published
‘Covaxin’s efficacy expected to be more than 90%’: PGI Rohtak’s V-C [Video]

‘Covaxin’s efficacy expected to be more than 90%’: PGI Rohtak’s V-C

The third-phase trial of Bharat Biotech's Covid-19 vaccine candidate, Covaxin will begin from November 20. Pandit Bhagwat Dayal Sharma Post Graduate Institute of Medical Sciences (PGIMS), Rohtak, hopes..

Credit: HT Digital Content     Duration: 02:29Published
Covaxin's efficacy expected to be more than 90%: Dr OP Kalra [Video]

Covaxin's efficacy expected to be more than 90%: Dr OP Kalra

Vice-Chancellor of Pt BD Sharma University of Health Sciences, (Rohtak), OP Kalra during a press conference on November 18 said that the third phase of Covaxin will start from November 20. OP Kalra..

Credit: ANI     Duration: 01:58Published